✦ LIBER ✦

621 A simple non-invasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy

✍ Scribed by M.L. Yu; C.Y. Dai; W.Y. Chang; W.L. Chuang

Book ID: 117374897
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 117 KB
Volume: 44
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(06)80621-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A simple noninvasive index for predictin

A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy

✍ Ming-Lung Yu; Shi-Ming Lin; Chuan-Mo Lee; Chia-Yen Dai; Wen-Yu Chang; Shinn-Cher 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Changes in hepatic fibrosis after interferon-based therapy may be important in determining the long-term outcome of chronic hepatitis C (CHC). The use of liver biopsy for posttreatment assessment is not a viable option as a routine follow-up procedure. This study evaluated the predictive value of a

Long-term outcome of chronic hepatitis C

Long-term outcome of chronic hepatitis C after sustained virological response to interferon-based therapy

✍ Koh, C.; Heller, T.; Haynes-Williams, V.; Hara, K.; Zhao, X.; Feld, J. J.; Klein 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

APRI-M6 for predicting long-term outcome

APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers

✍ Tung-Hung Su; Jia-Horng Kao; Ding-Shinn Chen 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views

We recognize the confusing terminology but can confirm that the gene we cloned and sequenced from the mouse genomic library and therefore subsequently knocked out is definitely RegIIIbeta, which we also name as Reg-2 because it is the homolog of rat Reg-2. To clarify the terminology, Table compare

Long-term monitoring of platelet count,

Long-term monitoring of platelet count, as a non-invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy

✍ Hideaki Taniguchi; Yoshiaki Iwasaki; Akiko Fujiwara; Kohsaku Sakaguchi; Akio Mor 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Prediction of successful outcome in a ra

Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C

✍ Vandelli, Carmen; Renzo, Francesco; Braun, Hans Bertram; Tisminetzky, Sergio; Al 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

To evaluate the efficacy of a 12-month course of recombinant interferon alpha (IFN-␣2b), and to assess predictive factors of successful response to IFN therapy in chronic active hepatitis C (HCV CAH), 242 patients with histologically proven HCV CAH were assigned randomly to two groups, one treated w

The clinical value of grading and stagin

The clinical value of grading and staging scores for predicting a long-term response and evaluating the efficacy of interferon therapy in chronic hepatitis C

✍ Michiko Shindo; Ken Arai; Tadao Okuno 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 658 KB